Contact Information

Currently Enrolling Trials

General Information

Ketoprofen, the generic equivalent of Wyeth Ayerst's Oruvail, has received approval as a non-steroidal anti-inflammatory. Ketoprofen will be available in 200 mg extended release capsules.

Approval Date: 1997-12-01

Company Name: Schein Pharmaceutical

Back to Listings

28Sep
4th Annual WCG MCC Clinical Trial Risk & Performance Management Collaborative vSummit
12Oct
Effective Root Cause Analysis and CAPA Investigations for the Life Sciences
18Oct
MAGI's Clinical Research vConference — Fall 2021
16Nov
16th Annual FDA Inspections vSummit

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here

Ketoprofen

Profile

Contact Information

Currently Enrolling Trials

General Information

Upcoming Events

4th Annual WCG MCC Clinical Trial Risk & Performance Management Collaborative vSummit

Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

MAGI's Clinical Research vConference — Fall 2021

16th Annual FDA Inspections vSummit

Featured Products

Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

Sites Face Tighter Imaging Needs for Certain Trials as Use of Imaging Keeps Climbing

Ask the Experts: Questions about Advertising for Clinical Trials

Getting Through Inspections: Seasoned Research Institution Details Successful Strategies

Becoming ISO 9001-Certified Could Benefit Sites on GCP-Compliant Quality Frameworks

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.